EU antitrust authorities are scrutinizing Google's AI agreement with Samsung to assess whether it hampers rival chatbots on Samsung smartphones, according to a document reviewed by Reuters.
Requests for Information Issued
According to an EU document that was viewed by Reuters, antitrust investigators in the European Union are asking players in the sector whether or not Google's multi-year generative artificial intelligence (AI) arrangement with Samsung makes it more difficult for competitors to implement chatbots on Samsung smartphones.
Earlier this month, the European Commission announced that it will be sending requests for information in order to gain a better understanding of the impacts of the arrangement, which would involve Samsung embedding Google's Gemini Nano in Samsung's Galaxy S24 series of Android handsets.
In the event that the EU antitrust enforcer discovers any anti-competitive conduct, this step may be of assistance to the firm in constructing a case against the corporations.
Pre-installation Concerns
In the questionnaire, it was inquired as to whether the pre-installation of Gemini Nano on the device itself or through the cloud imposes a restriction on the number of other generative artificial intelligence systems that can be pre-installed on another device.
Also, regulators were interested in learning whether or not the pre-installation of Gemini Nano restricts the capacity of other chatbots and applications that are pre-installed on Samsung smartphones to communicate with one another.
Questionnaire Submission Deadline
Per Investing.com, the respondents were asked whether they had attempted to get pre-installation agreements with device makers but had been unsuccessful in doing so, and if so, the reasons for their failure were specified.
Respondents have till this week to provide their responses to the questionnaire, which is eight pages long.


Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Google Halts UK YouTube TV Measurement Service After Legal Action
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 



